Make Home Page | Bookmark this page      
    
HOME
ABOUT US
SERVICES
BACK OFFICE
RESEARCH
ONLINE TRADING
Market
  
Market Analysis Company Information Corporate Actions Other Market
        Gainers & Losers         Advances & Declines         New Highs & Lows         Out / Under Performers
        Index Movers         Historical Returns         Sector Watch         Only Buyers and Sellers
        Value & Volume Toppers         Live Indices         Bulk Deals         Block Deals
        52 Week Highs & Lows         Exchange Holidays         Unusual Volume         Index Constituents
        Detailed Quotes         Company Snapshot         Board of Directors         Profit & Loss
        Quarterly Result         Balance Sheet         Key Financial Ratios         Monthly High Low
        Name Change         Company News         MF Holdings         Director's Report
        Peer Comparison         Company Background         Score Board         Share Holding Pattern
        Technical Chart         Interactive Chart
        BSE Announcements         NSE Announcements         Board Meetings         Book Closure
        Bonus Issues         Rights Issues         De-Listed Shares         Market Turnover
        Change Of Name         Split Of Face Value
        ADR Prices         Forex         FII Investment         MF Investment
        World Indices
Profit & Loss
Lupin Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
500257
ISIN Demat
INE326A01037
Book Value
422.9660038
NSE Symbol
LUPIN
Div & Yield %
0.24
Market Cap (Rs. Cr.)
75438.04
P/E
36.60
EPS
45.22
Face Value
2
The purpose of the income statement is to show managers and investors whether the company made or lost money during the period being reported.
Home >> Equity >> Company Information >> Profit & Loss
 Mar 2023
Rs.Cr
Mar 2022
Rs.Cr
Mar 2021
Rs.Cr
Mar 2020
Rs.Cr
Mar 2019
Rs.Cr
Mar 2018
Rs.Cr
INCOME :      
Sales Turnover 11258.8311771.6711055.9311025.6611356.3210088.18
Excise Duty0.000.000.000.000.007.60
Net Sales11258.8311771.6711055.9311025.6611356.3210080.58
Other Income 210.02216.99129.09475.19291.34131.12
Stock Adjustments -120.79242.3881.8628.72147.23-84.67
Total Income11348.0612231.0411266.8811529.5711794.8910127.03
EXPENDITURE :      
Raw Materials 4676.904709.644264.174235.994040.133389.68
Power & Fuel Cost447.42418.45389.54416.26416.30381.32
Employee Cost 1934.141918.161695.861703.221515.421441.64
Other Manufacturing Expenses 1155.601209.091135.791108.701050.871194.38
Selling & Administrative Expenses 1797.131573.221355.011557.701488.581416.04
Miscellaneous Expenses 162.951976.35253.36884.11479.4586.99
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure10174.1411804.919093.739905.988990.757910.05
Operating Profit1173.92426.132173.151623.592804.142216.98
Interest 98.4473.4740.6252.5935.4733.24
Gross Profit1075.48352.662132.531571.002768.672183.74
Depreciation548.34514.19502.83518.75426.30389.81
Profit Before Tax527.14-161.531629.701052.252342.371793.93
Tax95.8957.80362.85362.05795.00386.57
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax6.04-30.638.23-37.358.5462.70
Reported Net Profit425.21-188.701258.62727.551538.831344.66
Extraordinary Items 14.4230.6441.61-425.63-205.1530.93
Adjusted Net Profit410.79-219.341217.011153.181743.981313.73
Adjustment below Net Profit -1.392.42-7.89-135.66-46.47-68.97
P & L Balance brought forward15032.7415514.1014535.2514227.3412961.0612024.18
Statutory Appropriations0.000.000.000.000.000.00
Appropriations 181.85295.08271.88226.30226.08338.81
P & L Balance carried down15274.7115032.7415514.1014592.9314227.3412961.06
Dividend0.000.000.000.000.00226.04
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %200.00200.00325.00300.00250.00250.00
Dividend Per Share(Rs)4.004.006.506.005.005.00
Earnings Per Share-Unit Curr9.35-4.1527.7416.0634.0129.74
Earnings Per Share(Adj)-Unit Curr9.35-4.1527.7416.0634.0129.74
Book Value-Unit Curr404.66399.34409.20385.72378.28349.15
Book Value(Adj)-Unit Curr404.66399.34409.20385.72378.28349.15